Decoy Therapeutics Inc. Common Stock
Veridion Score
Composite trend over time
Why is DCOY moving today?
Decoy Therapeutics Inc is a pre-clinical stage biotechnology company focused on advancing its pipeline of peptide conjugate therapeutics engineered through its proprietary IMP3ACT platform. The IMP3ACT platform represents a paradigm shift in peptide conjugate drug discovery and manufacturing, leveraging machine learning (ML) and artificial intelligence (AI" tools alongside high-speed synthesis techniques to rapidly engineer, optimize and manufacture peptide conjugates that target serious unmet medical needs. The company manages its business in one operating segment, focused on the discovery and development therapeutics for patients with high, unmet medical needs. Its pipeline programs include: Pan-Coronavirus; and Tripledemic.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Warehouse intelligence for DCOY.
DCOY insider activity
Decoy Therapeutics Inc. Common Stock
No multi-insider buying cluster in the last 90 days
Mixed: Not disclosed across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
The current Form 4 feed did not return value-bearing open-market rows for DCOY.
DCOY contract awards, year to date.
Public federal awards linked to this ticker.
DCOY lobbying filings, year to date.
Registered lobbying filings matched to Decoy Therapeutics Inc. Common Stock.